APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Dopamine Receptors

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dopamine Receptors Industry Growth and Trends Forecast to 2032

Report ID 17390434018 January 2026113 pages

Choose your research edition.

Industry ResearchDopamine Receptors Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Dopamine Receptors Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Dopamine Receptors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dopamine Receptors Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Dopamine Receptors Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Dopamine Receptors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dopamine Receptors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dopamine Receptors is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dopamine Receptors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dopamine Receptors include Abcam, Merck, Bio‑Techne, Cell Signaling Technology, Novus Biologicals, Santa Cruz Biotechnology, Bio‑Rad, United States Biological and Alomone Labs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dopamine Receptors market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dopamine Receptors market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dopamine Receptors market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dopamine Receptors.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dopamine Receptors market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dopamine Receptors Market by Company

Abcam

Merck

Bio‑Techne

Cell Signaling Technology

Novus Biologicals

Santa Cruz Biotechnology

Bio‑Rad

United States Biological

Alomone Labs

MedChemExpress

Sino Biological

Abbkine

BioLegend

Genetex

Synaptic Systems

Dopamine Receptors Segment by Type

D1-like Receptors

D2-like Receptors

Dopamine Receptors Segment by Application

Life Science Research

Drug Development and Target Validation

Animal Models and Preclinical Studies

Others

Dopamine Receptors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dopamine Receptors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dopamine Receptors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dopamine Receptors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dopamine Receptors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dopamine Receptors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of D1-like Receptors Table 2. Major Company of D2-like Receptors Table 3. Global Dopamine Receptors Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Dopamine Receptors Sales by Type (2021-2026) & (k units) Table 5. Global Dopamine Receptors Sales Market Share in Volume by Type (2021-2026) Table 6. Global Dopamine Receptors Sales by Type (2021-2026) & (US$ Million) Table 7. Global Dopamine Receptors Sales Market Share in Value by Type (2021-2026) Table 8. Global Dopamine Receptors Price by Type (2021-2026) & (USD/unit) Table 9. Global Dopamine Receptors Sales by Type (2027-2032) & (k units) Table 10. Global Dopamine Receptors Sales Market Share in Volume by Type (2027-2032) Table 11. Global Dopamine Receptors Sales by Type (2027-2032) & (US$ Million) Table 12. Global Dopamine Receptors Sales Market Share in Value by Type (2027-2032) Table 13. Global Dopamine Receptors Price by Type (2027-2032) & (USD/unit) Table 14. North America Dopamine Receptors Sales by Type (2021-2026) & (k units) Table 15. North America Dopamine Receptors Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Dopamine Receptors Sales by Type (2021-2026) & (k units) Table 17. Europe Dopamine Receptors Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Dopamine Receptors Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Dopamine Receptors Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Dopamine Receptors Sales by Type (2021-2026) & (k units) Table 21. Latin America Dopamine Receptors Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Dopamine Receptors Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Dopamine Receptors Sales by Type (2021-2026) & (US$ Million) Table 24. Dopamine Receptors Industry Trends Table 25. Dopamine Receptors Industry Drivers Table 26. Dopamine Receptors Industry Opportunities and Challenges Table 27. Dopamine Receptors Industry Restraints Table 28. Global Dopamine Receptors Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Dopamine Receptors Revenue Market Share by Company (2021-2026) Table 30. Global Dopamine Receptors Sales by Company (2021-2026) & (k units) Table 31. Global Dopamine Receptors Sales Share by Company (2021-2026) Table 32. Global Dopamine Receptors Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Dopamine Receptors Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Dopamine Receptors Major Company Production Sites and Headquarters Table 35. Global Dopamine Receptors Company, Product Type & Application Table 36. Global Dopamine Receptors Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Dopamine Receptors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Dopamine Receptors Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Dopamine Receptors Sales by Region (2021-2026) & (k units) Table 41. Global Dopamine Receptors Sales Market Share in Volume by Region (2021-2026) Table 42. Global Dopamine Receptors Sales by Region (2021-2026) & (US$ Million) Table 43. Global Dopamine Receptors Sales Market Share in Value by Region (2021-2026) Table 44. Global Dopamine Receptors Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Dopamine Receptors Sales by Region (2027-2032) & (k units) Table 46. Global Dopamine Receptors Sales Market Share in Volume by Region (2027-2032) Table 47. Global Dopamine Receptors Sales by Region (2027-2032) & (US$ Million) Table 48. Global Dopamine Receptors Sales Market Share in Value by Region (2027-2032) Table 49. Global Dopamine Receptors Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Dopamine Receptors Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Dopamine Receptors Sales by Application (2021-2026) & (k units) Table 52. Global Dopamine Receptors Sales Market Share in Volume by Application (2021-2026) Table 53. Global Dopamine Receptors Sales by Application (2021-2026) & (US$ Million) Table 54. Global Dopamine Receptors Sales Market Share in Value by Application (2021-2026) Table 55. Global Dopamine Receptors Price by Application (2021-2026) & (USD/unit) Table 56. Global Dopamine Receptors Sales by Application (2027-2032) & (k units) Table 57. Global Dopamine Receptors Sales Market Share in Volume by Application (2027-2032) Table 58. Global Dopamine Receptors Sales by Application (2027-2032) & (US$ Million) Table 59. Global Dopamine Receptors Sales Market Share in Value by Application (2027-2032) Table 60. Global Dopamine Receptors Price by Application (2027-2032) & (USD/unit) Table 61. North America Dopamine Receptors Sales by Application (2021-2026) & (k units) Table 62. North America Dopamine Receptors Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Dopamine Receptors Sales by Application (2021-2026) & (k units) Table 64. Europe Dopamine Receptors Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Dopamine Receptors Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Dopamine Receptors Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Dopamine Receptors Sales by Application (2021-2026) & (k units) Table 68. Latin America Dopamine Receptors Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Dopamine Receptors Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Dopamine Receptors Sales by Application (2021-2026) & (US$ Million) Table 71. Abcam Company Information Table 72. Abcam Business Overview Table 73. Abcam Dopamine Receptors Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Abcam Dopamine Receptors Product Portfolio Table 75. Abcam Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Dopamine Receptors Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Merck Dopamine Receptors Product Portfolio Table 80. Merck Recent Development Table 81. Bio‑Techne Company Information Table 82. Bio‑Techne Business Overview Table 83. Bio‑Techne Dopamine Receptors Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Bio‑Techne Dopamine Receptors Product Portfolio Table 85. Bio‑Techne Recent Development Table 86. Cell Signaling Technology Company Information Table 87. Cell Signaling Technology Business Overview Table 88. Cell Signaling Technology Dopamine Receptors Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Cell Signaling Technology Dopamine Receptors Product Portfolio Table 90. Cell Signaling Technology Recent Development Table 91. Novus Biologicals Company Information Table 92. Novus Biologicals Business Overview Table 93. Novus Biologicals Dopamine Receptors Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Novus Biologicals Dopamine Receptors Product Portfolio Table 95. Novus Biologicals Recent Development Table 96. Santa Cruz Biotechnology Company Information Table 97. Santa Cruz Biotechnology Business Overview Table 98. Santa Cruz Biotechnology Dopamine Receptors Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Santa Cruz Biotechnology Dopamine Receptors Product Portfolio Table 100. Santa Cruz Biotechnology Recent Development Table 101. Bio‑Rad Company Information Table 102. Bio‑Rad Business Overview Table 103. Bio‑Rad Dopamine Receptors Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Bio‑Rad Dopamine Receptors Product Portfolio Table 105. Bio‑Rad Recent Development Table 106. United States Biological Company Information Table 107. United States Biological Business Overview Table 108. United States Biological Dopamine Receptors Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. United States Biological Dopamine Receptors Product Portfolio Table 110. United States Biological Recent Development Table 111. Alomone Labs Company Information Table 112. Alomone Labs Business Overview Table 113. Alomone Labs Dopamine Receptors Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Alomone Labs Dopamine Receptors Product Portfolio Table 115. Alomone Labs Recent Development Table 116. MedChemExpress Company Information Table 117. MedChemExpress Business Overview Table 118. MedChemExpress Dopamine Receptors Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. MedChemExpress Dopamine Receptors Product Portfolio Table 120. MedChemExpress Recent Development Table 121. Sino Biological Company Information Table 122. Sino Biological Business Overview Table 123. Sino Biological Dopamine Receptors Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Sino Biological Dopamine Receptors Product Portfolio Table 125. Sino Biological Recent Development Table 126. Abbkine Company Information Table 127. Abbkine Business Overview Table 128. Abbkine Dopamine Receptors Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Abbkine Dopamine Receptors Product Portfolio Table 130. Abbkine Recent Development Table 131. BioLegend Company Information Table 132. BioLegend Business Overview Table 133. BioLegend Dopamine Receptors Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. BioLegend Dopamine Receptors Product Portfolio Table 135. BioLegend Recent Development Table 136. Genetex Company Information Table 137. Genetex Business Overview Table 138. Genetex Dopamine Receptors Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Genetex Dopamine Receptors Product Portfolio Table 140. Genetex Recent Development Table 141. Synaptic Systems Company Information Table 142. Synaptic Systems Business Overview Table 143. Synaptic Systems Dopamine Receptors Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Synaptic Systems Dopamine Receptors Product Portfolio Table 145. Synaptic Systems Recent Development Table 146. North America Dopamine Receptors Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. North America Dopamine Receptors Sales by Country (2021-2026) & (k units) Table 148. North America Dopamine Receptors Sales Market Share by Country (2021-2026) Table 149. North America Dopamine Receptors Sales Forecast by Country (2027-2032) & (k units) Table 150. North America Dopamine Receptors Sales Market Share Forecast by Country (2027-2032) Table 151. North America Dopamine Receptors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Dopamine Receptors Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Dopamine Receptors Market Share by Country (2021-2026) Table 154. North America Dopamine Receptors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Dopamine Receptors Market Share Forecast by Country (2027-2032) Table 156. Europe Dopamine Receptors Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Europe Dopamine Receptors Sales by Country (2021-2026) & (k units) Table 158. Europe Dopamine Receptors Sales Market Share by Country (2021-2026) Table 159. Europe Dopamine Receptors Sales Forecast by Country (2027-2032) & (k units) Table 160. Europe Dopamine Receptors Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Dopamine Receptors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Dopamine Receptors Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Dopamine Receptors Market Share by Country (2021-2026) Table 164. Europe Dopamine Receptors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Dopamine Receptors Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Dopamine Receptors Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Dopamine Receptors Sales by Country (2021-2026) & (k units) Table 168. Asia-Pacific Dopamine Receptors Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Dopamine Receptors Sales Forecast by Country (2027-2032) & (k units) Table 170. Asia-Pacific Dopamine Receptors Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Dopamine Receptors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Dopamine Receptors Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Dopamine Receptors Market Share by Country (2021-2026) Table 174. Asia-Pacific Dopamine Receptors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Dopamine Receptors Market Share Forecast by Country (2027-2032) Table 176. Latin America Dopamine Receptors Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Latin America Dopamine Receptors Sales by Country (2021-2026) & (k units) Table 178. Latin America Dopamine Receptors Sales Market Share by Country (2021-2026) Table 179. Latin America Dopamine Receptors Sales Forecast by Country (2027-2032) & (k units) Table 180. Latin America Dopamine Receptors Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Dopamine Receptors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Dopamine Receptors Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Dopamine Receptors Market Share by Country (2021-2026) Table 184. Latin America Dopamine Receptors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Dopamine Receptors Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Dopamine Receptors Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Dopamine Receptors Sales by Country (2021-2026) & (k units) Table 188. Middle East and Africa Dopamine Receptors Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Dopamine Receptors Sales Forecast by Country (2027-2032) & (k units) Table 190. Middle East and Africa Dopamine Receptors Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Dopamine Receptors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Dopamine Receptors Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Dopamine Receptors Market Share by Country (2021-2026) Table 194. Middle East and Africa Dopamine Receptors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Dopamine Receptors Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Dopamine Receptors Distributors List Table 199. Dopamine Receptors Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Dopamine Receptors Image Figure 2. Global Dopamine Receptors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dopamine Receptors Market Size (2021-2032) & (US$ Million) Figure 4. Global Dopamine Receptors Sales (2021-2032) & (k units) Figure 5. D1-like Receptors Image Figure 6. Global D1-like Receptors Sales YoY Growth (2021-2032) & (k units) Figure 7. D2-like Receptors Image Figure 8. Global D2-like Receptors Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Dopamine Receptors Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Dopamine Receptors Market Share by Type 2025 VS 2032 Figure 11. North America Dopamine Receptors Sales Market Share in Volume by Type in 2025 Figure 12. North America Dopamine Receptors Sales Market Share in Value by Type in 2025 Figure 13. Europe Dopamine Receptors Sales Market Share in Volume by Type in 2025 Figure 14. Europe Dopamine Receptors Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Dopamine Receptors Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Dopamine Receptors Sales Market Share in Value by Type in 2025 Figure 17. Latin America Dopamine Receptors Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Dopamine Receptors Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Dopamine Receptors Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Dopamine Receptors Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Dopamine Receptors Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Life Science Research Image Figure 24. Global Life Science Research Sales YoY Growth (2021-2032) & (k units) Figure 25. Drug Development and Target Validation Image Figure 26. Global Drug Development and Target Validation Sales YoY Growth (2021-2032) & (k units) Figure 27. Animal Models and Preclinical Studies Image Figure 28. Global Animal Models and Preclinical Studies Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Dopamine Receptors Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Dopamine Receptors Market Share by Application 2025 VS 2032 Figure 33. North America Dopamine Receptors Sales Market Share in Volume by Application in 2025 Figure 34. North America Dopamine Receptors Sales Market Share in Value by Application in 2025 Figure 35. Europe Dopamine Receptors Sales Market Share in Volume by Application in 2025 Figure 36. Europe Dopamine Receptors Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Dopamine Receptors Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Dopamine Receptors Sales Market Share in Value by Application in 2025 Figure 39. Latin America Dopamine Receptors Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Dopamine Receptors Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Dopamine Receptors Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Dopamine Receptors Sales Market Share in Value by Application in 2025 Figure 43. North America Dopamine Receptors Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Dopamine Receptors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Dopamine Receptors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Dopamine Receptors Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Dopamine Receptors Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Dopamine Receptors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Dopamine Receptors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Dopamine Receptors Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Dopamine Receptors Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Dopamine Receptors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Dopamine Receptors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Dopamine Receptors Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Dopamine Receptors Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Dopamine Receptors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Dopamine Receptors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Dopamine Receptors Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Dopamine Receptors Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Dopamine Receptors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Dopamine Receptors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Dopamine Receptors Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Dopamine Receptors Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Dopamine Receptors Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • D1-like Receptors
  • D2-like Receptors
Applications
  • Life Science Research
  • Drug Development and Target Validation
  • Animal Models and Preclinical Studies
  • Others
Companies covered
  • Abcam
  • Merck
  • Bio‑Techne
  • Cell Signaling Technology
  • Novus Biologicals
  • Santa Cruz Biotechnology
  • Bio‑Rad
  • United States Biological
  • Alomone Labs
  • MedChemExpress
  • Sino Biological
  • Abbkine
  • BioLegend
  • Genetex
  • Synaptic Systems

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dopamine Receptors Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dopamine Receptors Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dopamine Receptors Market by Type
  6. 1.3.1 D1-like Receptors
  7. 1.3.2 D2-like Receptors
  8. 1.4 Global Dopamine Receptors Market Size by Type
  9. 1.4.1 Global Dopamine Receptors Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Dopamine Receptors Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Dopamine Receptors Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Dopamine Receptors Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Dopamine Receptors Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Dopamine Receptors Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Dopamine Receptors Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Dopamine Receptors Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dopamine Receptors Industry Trends
  2. 2.2 Dopamine Receptors Industry Drivers
  3. 2.3 Dopamine Receptors Industry Opportunities and Challenges
  4. 2.4 Dopamine Receptors Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dopamine Receptors Revenue (2021-2026)
  2. 3.2 Global Top Players by Dopamine Receptors Sales (2021-2026)
  3. 3.3 Global Top Players by Dopamine Receptors Price (2021-2026)
  4. 3.4 Global Dopamine Receptors Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dopamine Receptors Major Company Production Sites & Headquarters
  6. 3.6 Global Dopamine Receptors Company, Product Type & Application
  7. 3.7 Global Dopamine Receptors Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dopamine Receptors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dopamine Receptors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dopamine Receptors Tier 1, Tier 2, and Tier 3
4 Dopamine Receptors Regional Status and Outlook
  1. 4.1 Global Dopamine Receptors Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dopamine Receptors Historic Market Size by Region
  3. 4.2.1 Global Dopamine Receptors Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dopamine Receptors Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dopamine Receptors Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dopamine Receptors Forecasted Market Size by Region
  7. 4.3.1 Global Dopamine Receptors Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dopamine Receptors Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dopamine Receptors Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dopamine Receptors by Application
  1. 5.1 Dopamine Receptors Market by Application
  2. 5.1.1 Life Science Research
  3. 5.1.2 Drug Development and Target Validation
  4. 5.1.3 Animal Models and Preclinical Studies
  5. 5.1.4 Others
  6. 5.2 Global Dopamine Receptors Market Size by Application
  7. 5.2.1 Global Dopamine Receptors Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Dopamine Receptors Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Dopamine Receptors Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Dopamine Receptors Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Dopamine Receptors Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Dopamine Receptors Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Dopamine Receptors Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Dopamine Receptors Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abcam
  2. 6.1.1 Abcam Company Information
  3. 6.1.2 Abcam Business Overview
  4. 6.1.3 Abcam Dopamine Receptors Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abcam Dopamine Receptors Product Portfolio
  6. 6.1.5 Abcam Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Dopamine Receptors Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Dopamine Receptors Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Bio‑Techne
  14. 6.3.1 Bio‑Techne Company Information
  15. 6.3.2 Bio‑Techne Business Overview
  16. 6.3.3 Bio‑Techne Dopamine Receptors Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bio‑Techne Dopamine Receptors Product Portfolio
  18. 6.3.5 Bio‑Techne Recent Developments
  19. 6.4 Cell Signaling Technology
  20. 6.4.1 Cell Signaling Technology Company Information
  21. 6.4.2 Cell Signaling Technology Business Overview
  22. 6.4.3 Cell Signaling Technology Dopamine Receptors Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Cell Signaling Technology Dopamine Receptors Product Portfolio
  24. 6.4.5 Cell Signaling Technology Recent Developments
  25. 6.5 Novus Biologicals
  26. 6.5.1 Novus Biologicals Company Information
  27. 6.5.2 Novus Biologicals Business Overview
  28. 6.5.3 Novus Biologicals Dopamine Receptors Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novus Biologicals Dopamine Receptors Product Portfolio
  30. 6.5.5 Novus Biologicals Recent Developments
  31. 6.6 Santa Cruz Biotechnology
  32. 6.6.1 Santa Cruz Biotechnology Company Information
  33. 6.6.2 Santa Cruz Biotechnology Business Overview
  34. 6.6.3 Santa Cruz Biotechnology Dopamine Receptors Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Santa Cruz Biotechnology Dopamine Receptors Product Portfolio
  36. 6.6.5 Santa Cruz Biotechnology Recent Developments
  37. 6.7 Bio‑Rad
  38. 6.7.1 Bio‑Rad Company Information
  39. 6.7.2 Bio‑Rad Business Overview
  40. 6.7.3 Bio‑Rad Dopamine Receptors Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bio‑Rad Dopamine Receptors Product Portfolio
  42. 6.7.5 Bio‑Rad Recent Developments
  43. 6.8 United States Biological
  44. 6.8.1 United States Biological Company Information
  45. 6.8.2 United States Biological Business Overview
  46. 6.8.3 United States Biological Dopamine Receptors Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 United States Biological Dopamine Receptors Product Portfolio
  48. 6.8.5 United States Biological Recent Developments
  49. 6.9 Alomone Labs
  50. 6.9.1 Alomone Labs Company Information
  51. 6.9.2 Alomone Labs Business Overview
  52. 6.9.3 Alomone Labs Dopamine Receptors Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Alomone Labs Dopamine Receptors Product Portfolio
  54. 6.9.5 Alomone Labs Recent Developments
  55. 6.10 MedChemExpress
  56. 6.10.1 MedChemExpress Company Information
  57. 6.10.2 MedChemExpress Business Overview
  58. 6.10.3 MedChemExpress Dopamine Receptors Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 MedChemExpress Dopamine Receptors Product Portfolio
  60. 6.10.5 MedChemExpress Recent Developments
  61. 6.11 Sino Biological
  62. 6.11.1 Sino Biological Company Information
  63. 6.11.2 Sino Biological Business Overview
  64. 6.11.3 Sino Biological Dopamine Receptors Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sino Biological Dopamine Receptors Product Portfolio
  66. 6.11.5 Sino Biological Recent Developments
  67. 6.12 Abbkine
  68. 6.12.1 Abbkine Company Information
  69. 6.12.2 Abbkine Business Overview
  70. 6.12.3 Abbkine Dopamine Receptors Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Abbkine Dopamine Receptors Product Portfolio
  72. 6.12.5 Abbkine Recent Developments
  73. 6.13 BioLegend
  74. 6.13.1 BioLegend Company Information
  75. 6.13.2 BioLegend Business Overview
  76. 6.13.3 BioLegend Dopamine Receptors Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 BioLegend Dopamine Receptors Product Portfolio
  78. 6.13.5 BioLegend Recent Developments
  79. 6.14 Genetex
  80. 6.14.1 Genetex Company Information
  81. 6.14.2 Genetex Business Overview
  82. 6.14.3 Genetex Dopamine Receptors Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Genetex Dopamine Receptors Product Portfolio
  84. 6.14.5 Genetex Recent Developments
  85. 6.15 Synaptic Systems
  86. 6.15.1 Synaptic Systems Company Information
  87. 6.15.2 Synaptic Systems Business Overview
  88. 6.15.3 Synaptic Systems Dopamine Receptors Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Synaptic Systems Dopamine Receptors Product Portfolio
  90. 6.15.5 Synaptic Systems Recent Developments
7 North America by Country
  1. 7.1 North America Dopamine Receptors Sales by Country
  2. 7.1.1 North America Dopamine Receptors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dopamine Receptors Sales by Country (2021-2026)
  4. 7.1.3 North America Dopamine Receptors Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dopamine Receptors Market Size by Country
  6. 7.2.1 North America Dopamine Receptors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dopamine Receptors Market Size by Country (2021-2026)
  8. 7.2.3 North America Dopamine Receptors Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dopamine Receptors Sales by Country
  2. 8.1.1 Europe Dopamine Receptors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dopamine Receptors Sales by Country (2021-2026)
  4. 8.1.3 Europe Dopamine Receptors Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dopamine Receptors Market Size by Country
  6. 8.2.1 Europe Dopamine Receptors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dopamine Receptors Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dopamine Receptors Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dopamine Receptors Sales by Country
  2. 9.1.1 Asia-Pacific Dopamine Receptors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dopamine Receptors Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dopamine Receptors Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dopamine Receptors Market Size by Country
  6. 9.2.1 Asia-Pacific Dopamine Receptors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dopamine Receptors Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dopamine Receptors Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dopamine Receptors Sales by Country
  2. 10.1.1 South America Dopamine Receptors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dopamine Receptors Sales by Country (2021-2026)
  4. 10.1.3 South America Dopamine Receptors Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dopamine Receptors Market Size by Country
  6. 10.2.1 South America Dopamine Receptors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dopamine Receptors Market Size by Country (2021-2026)
  8. 10.2.3 South America Dopamine Receptors Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dopamine Receptors Sales by Country
  2. 11.1.1 Middle East and Africa Dopamine Receptors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dopamine Receptors Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dopamine Receptors Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dopamine Receptors Market Size by Country
  6. 11.2.1 Middle East and Africa Dopamine Receptors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dopamine Receptors Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dopamine Receptors Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dopamine Receptors Value Chain Analysis
  2. 12.1.1 Dopamine Receptors Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dopamine Receptors Production Mode & Process
  7. 12.2 Dopamine Receptors Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dopamine Receptors Distributors
  10. 12.2.3 Dopamine Receptors Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst